Tonix Pharmaceuticals Announces Presentation of Two Posters at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

NEXT STORY
ContraFect Announces Multiple Publications on Exebacase, Including First Manuscript on Local Administration of Lysin for Potential Treatment of Prosthetic Joint Infections
PREV STORY
Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company’s Chikungunya Virus Virus-Like Particle Vaccine Candidate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytori Reports Bioequivalence Trial Results in Ovarian Cancer at AAPS

Pharmacokinetic Bioequivalence Shown for Cytori’s ATI-0918 Liposomal Formulation of Doxorubicin Hydrochloride, Results Presented at ...

author_avatar
NASDAQ Market News

GBS Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology

author_avatar
NASDAQ Market News

SpringWorks Therapeutics to Participate in H.C. Wainwright Precision Oncology Investor Conference

author_avatar
NASDAQ Market News